Ozempic producer CEO in hot seat in congressional hearing

Senators grilled Novo Nordisk CEO Lars Jrgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, requesting explanations for why the U.S. faces a higher list price than other countries.

Since first entering the market nearly six years ago, the drugs have risen in popularity for diabetic patients and others looking to combat obesity. But doctors and patients have faced challenges in access and affordability.
#ozempic #ozempicweightloss #health #politics #news #fypage #fyp